跳至主要内容
临床试验/CTRI/2025/12/099175
CTRI/2025/12/099175尚未招募4 期

A prospective, randomized study to compare the efficacy of Tramadol versus Nalbuphine as adjuvants to Ropivacaine in transversus abdominis plane block for post-operative analgesia in patients undergoing elective abdominal hysterectomy under spinal anesthesia.

Smt Bhikiben Kanjibhai Shah Medical Institute and Research Center1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年12月30日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
60
试验地点
1

研究概览

简要总结

Elective abdominal hysterectomy often results in significant postoperative pain, making effective analgesia essential for recovery. Regional anesthesia, particularly spinal anesthesia and the transversus abdominis plane (TAP) block, offers advantages such as reduced systemic drug use, fewer side effects, and improved postoperative comfort. TAP block provides analgesia by depositing local anesthetics in the neurofascial plane to block T7–L1 nerves. Ropivacaine is preferred for its safety and selective sensory block. Adjuvants like tramadol and nalbuphine enhance and prolong analgesia with fewer adverse effects. This study compares their effectiveness in postoperative pain control, hemodynamic stability, and sedation in abdominal hysterectomy patients.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient giving consent Patient with asa grade 1,2 Patient posted for elective abdominal hysterectomy surgery under spinal anaesthesia.

排除标准

  • Patient not giving consent Patient with asa grade 3,4,5 Patient who is having comorbidities like diabetes and hypertension.

研究者

发起方
Smt Bhikiben Kanjibhai Shah Medical Institute and Research Center
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Shirali Deliwala

Smt. Bhikiben Kanjibhai Shah Medical Institute and Research Centre

研究点 (1)

Loading locations...

相似试验